Royalty Pharma PLC
NASDAQ:RPRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Royalty Pharma PLC
NASDAQ:RPRX
|
US |
|
Vranken Pommery Monopole SA
PAR:VRAP
|
FR |
|
Royalty Pharma PLC
F:RPD
|
US |
|
IRIDEX Corp
NASDAQ:IRIX
|
US |
|
B
|
Bank of Communications Co Ltd
XMUN:C4C
|
CN |
|
Pacific Ridge Exploration Ltd
OTC:PEXZD
|
CA |
|
Bioretec Oy
F:0TN
|
FI |
|
St James's Place PLC
OTC:STJPF
|
UK |
|
Rexel SA
F:E7V0
|
FR |
|
ProAssurance Corp
NYSE:PRA
|
US |
|
M
|
Mitchells & Butlers PLC
F:MABB
|
UK |
|
Granite Ridge Resources Inc
F:Y60
|
US |
|
E
|
Eversource Energy
DUS:NWJ
|
US |
|
J
|
Johnson Matthey PLC
XMUN:JMT2
|
UK |
Dividends
Dividend Yield
Royalty Pharma PLC
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Royalty Pharma PLC
RPRX have increased by 42%.
Payout Ratio
Royalty Pharma PLC
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for RPRX is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
RPRX Price
Royalty Pharma PLC
| Average Annual Return | -5.93% |
| Standard Deviation of Annual Returns | 14.58% |
| Max Drawdown | -42% |
| Market Capitalization | 34B USD |
| Shares Outstanding | 575 830 000 |
| Percentage of Shares Shorted | 2.85% |
